This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fauchais, A-L Articles by Hatron, P-Y Search for Related Content PubMed PubMed Citation Articles by Fauchais, A-L Articles by Hatron, P-Y Social Bookmarking                         What's this?

Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients

Department of Internal Medicine, Regional University Hospital of Lille, France, alfauchais{at}caramail.com

M Lambert

Department of Internal Medicine, Regional University Hospital of Lille, France

D Launay

Department of Internal Medicine, Regional University Hospital of Lille, France

U Michon-Pasturel

Department of Internal Medicine, Regional University Hospital of Lille, France

V Queyrel

Department of Internal Medicine, Regional University Hospital of Lille, France

N Nguyen

Department of Internal Medicine, Regional University Hospital of Lille, France

M Hebbar

Department of Internal Medicine, Regional University Hospital of Lille, France

E Hachulla

Department of Internal Medicine, Regional University Hospital of Lille, France

B Devulder

Department of Internal Medicine, Regional University Hospital of Lille, France

P-Y Hatron

Department of Internal Medicine, Regional University Hospital of Lille, France

The aim of this study is to determine prevalence, clinical significance of antiphospholipidantibodies (aPL) including anticardiolipin antibodies (aCL), anti-b2GP1 and lupus anticoagulant (LA) in a cohort of 74 patients with primary Sjögren’s syndrome (pSS) according to revised European criteria. aPL were found in 25 (34%) patients; IgG in 23 (12 had low titres, six moderate titres and five high titres) and IgM in five (three and two had respectively moderate and high titres). Eight (11%) patients were found to have LA; anti-b2GP1 antibodies were detected only in three (4%) patients. Only two patients with LA, aPL and b2GP1 had recurrent venous thrombosis. One patient with moderate titres of aPL exhibited recurrent spontaneous foetal losses. Peripheral neuropathies without cryoglobulinemia were more frequent in the aPL group. Other systemic involvements of pSS were the same in both groups with or without aPL. Patients with aPL have more concurrentimmunological diseases such as thyroiditis and primary biliary cirrhosis and a higher prevalence of hypergammaglobulinemia (P < 0.05). Even if aPL prevalence reached 30% in pSS, titres were usually low, with a close correlation with hypergammaglobulinemia but not with antiphospholipid syndrome, which is related to positivity of both LA and aPL.

Key Words: antiphospholipid antibodies • hypergammaglobulinemia • Sjögren’s syndrome

Lupus, Vol. 13, No. 4, 245-248 (2004)
DOI: 10.1191/0961203304lu1006oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I Uthman, I Salti, and M Khamashta Endocrinologic Manifestations of the Antiphospholipid Syndrome Lupus, August 1, 2006; 15(8): 485 - 489. [Abstract] [PDF]